Prevalence of insulin resistance (IR) and impact on treatment in chronic hepatitis C (CHC).

被引：0
|
作者：
Lok, AS
Everhart, JE
Chung, RT
Padmanabhan, L
Shiffman, ML
Everson, GT
Lindsay, KL
Bonkovsky, HL
di Bisceglie, AM
Lee, WM
Ghany, MG
Morishima, C
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] NIDDK, NIH, Bethesda, MD USA
[3] Massachusetts Gen Hosp, Boston, MA 02114 USA
[4] New England Res Inst, Watertown, MA 02172 USA
[5] Virginia Commonwealth Univ, Richmond, VA USA
[6] Univ Colorado, Denver, CO 80202 USA
[7] Univ So Calif, Los Angeles, CA USA
[8] Univ Connecticut, Farmington, CT USA
[9] St Louis Univ, St Louis, MO 63103 USA
[10] Univ Texas SW, Dallas, TX USA
[11] Univ Calif Irvine, Irvine, CA USA
[12] Univ Washington, Seattle, WA 98195 USA
来源：
HEPATOLOGY | 2004年 / 40卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：314A / 315A
页数：2
相关论文
共 50 条
  • [31] The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients
    Jung, Hee Jae
    Kim, Young Seok
    Kim, Sang Gyune
    Lee, Yun Nah
    Jeong, Soung Won
    Jang, Jae Young
    Lee, Sae Hwan
    Kim, Hong Soo
    Kim, Boo Sung
    CLINICAL AND MOLECULAR HEPATOLOGY, 2014, 20 (01) : 38 - 46
  • [32] Impact of high serum glucose on liver fibrosis in chronic hepatitis C (CHC)
    Ratziu, VD
    Munteanu, M
    Bonyhay, L
    Charlotte, F
    Opolon, P
    Poynard, T
    JOURNAL OF HEPATOLOGY, 2001, 34 : 163 - 164
  • [33] Impact of obesity, hepatic steatosis, and insulin resistance on hepatitis C treatment outcomes
    Elgouhari H.M.
    Conjeevaram H.S.
    Current Hepatitis Reports, 2008, 7 (3) : 127 - 133
  • [34] Lesions compatible with alcohol intake (LCAI) in chronic hepatitis C (CHC) patients:: Prevalence and response to combined treatment.
    Trapero-Marugan, M
    Moreno-Monteagudo, JA
    García-Buey, L
    Borque, MJ
    Garcia-Sanchez, A
    Moreno-Otero, R
    HEPATOLOGY, 2002, 36 (04) : 407A - 407A
  • [35] The impact of body mass index (BMI) on liver histology and treatment tolerability and efficacy in chronic hepatitis C (CHC)
    Harvin, GK
    Miles, LG
    Huntley, NL
    Willner, IR
    Reuben, A
    GASTROENTEROLOGY, 2003, 124 (04) : A704 - A704
  • [36] Adipokines and insulin resistance in chronic hepatitis C - Reply
    Cua, Ian Homer Y.
    George, Jacob
    HEPATOLOGY, 2007, 46 (06) : 2051 - 2051
  • [37] DEGREE OF CHRONIC HEPATITIS C SEVERITY AND INSULIN RESISTANCE
    Ibrahim, Abdul Razak Kelana
    Setiawan, Poernomo Boedi
    Soelistijo, Soebagijo Adi
    Nusi, Iswan Abbas
    Maimunah, Ummi
    Purbayu, Herry
    Kholili, Ulfa
    Widodo, Budi
    Thamrin, Husin
    Miftahussurur, Muhammad
    Vidyani, Amie
    NEW ARMENIAN MEDICAL JOURNAL, 2019, 13 (01): : 27 - 34
  • [38] The insulin resistance of chronic hepatitis C is peripheral and not hepatic
    Milner, Kerry-Lee
    Chisholm, Donald J.
    Jenkins, Arthur B.
    Trenell, Michael I.
    Van der Poorten, David
    Fragomeli, Vincenzo
    Weltman, Martin
    Hui, Jason
    Dore, Greg
    Zekry, Amany
    George, Jacob
    DIABETES, 2008, 57 : A20 - A21
  • [39] Chronic Hepatitis C, Insulin Resistance and Vascular Disease
    Trpkovic, Andreja
    Stokic, Edith
    Radak, Djordje
    Gluvic, Zoran
    Haidara, Mohamed
    Mikhailidis, Dimitri P.
    Isenovic, Esma. R.
    CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (34) : 3823 - 3829
  • [40] Molecular mechanisms of insulin resistance in chronic hepatitis C
    Douglas, Mark W.
    George, Jacob
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (35) : 4356 - 4364
12345